MedPath

Study to find if weight loss surgery affects the symptoms of heartburn and vomiting

Not Applicable
Conditions
Health Condition 1: E662- Morbid (severe) obesity with alveolar hypoventilation
Registration Number
CTRI/2019/06/019705
Lead Sponsor
ADY HARDINGE MEDICAL COLLEGE
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1) Patients with morbid obesity of both genders, aging between 18 and 65 years will be included.

2) Patients with a body mass index (BMI) > 40 kg/m² or BMI > 35 kg/m² with obesity related comorbidities ( metabolic syndrome, Type 2 Diabetes Mellitus , Non alcoholic fatty liver disease, hyperlipidemia ,Hypertension and sleep apnea)

Exclusion Criteria

1) Patients who underwent previous bariatric surgery or upper gastrointestinal surgeries.

2) Patients with secondary obesity due to endocrine or metabolic diseases

3) Patients with psychiatric disorders

4) Patient with deep venous thrombosis.

5) Patients with Peptic ulcer disease, achlasia cardia.

6) Patients unfit for general anaesthesia.

7) Patients lost to follow up.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Gastroesophageal reflux ( GER ) before and 3 months after Laparoscopic Sleeve Gastrectomy ( LSG ) using 24 hour Multichannel Intraluminal Impedance (MII) pH monitoring in morbidly obese patientsTimepoint: Before and 3 months after surgery
Secondary Outcome Measures
NameTimeMethod
i.Excess weight loss after laparoscopic sleeve gastrectomy at 3 months duration. <br/ ><br>ii.Non-acidic reflux before and 3 months after Laparoscopic Sleeve Gastrectomy <br/ ><br>iii.To corelate MII pH manometery with Upper GI Endoscopy and GERD-Q scoring in morbidly obese patients undergoing Laparoscopic Sleeve Gastrectomy <br/ ><br>Timepoint: Before and 3 months after Surgery
© Copyright 2025. All Rights Reserved by MedPath